or Try an Advanced Search...

    Generic Pharmaceuticals Stocks List

    Symbol Grade Name % Change
    COSM F Cosmos Health Inc. 5.56
    BHC C Bausch Health Companies Inc. -0.12
    HSIC C Henry Schein, Inc. 0.05
    ABT B Abbott Laboratories -0.01
    View As Page of Charts
    Related Industries: Drug Manufacturers - Specialty & Generic Medical Devices Medical Distribution
    Related Stock Lists: Generic Pharmaceutical Contact Lens Eye Health Care Products Health Products Irritable Bowel Syndrome Life Sciences Pharmaceutical Products S&P 500 Abrasives Acne Actinic Keratosis Animal Health Animal Health Products Atopic Dermatitis Baby Products Biotechnology Blood Glucose Monitoring Cancer Cataract Surgery

    Related ETFs - A few ETFs which own one or more of the above listed Generic Pharmaceuticals stocks.

    Symbol Grade Name Weight
    IHI A iShares U.S. Medical Devices ETF 16.82
    PJP D PowerShares Dynamic Pharmaceuticals 5.77
    HART D IQ Healthy Hearts ETF 5.42
    PCGG B Polen Capital Global Growth ETF 4.56
    QLTY B GMO U.S. Quality ETF 4.17
    View all Generic Pharmaceuticals ETFs...
    Compare ETFs
    Compare HART to PCGG Compare IHI to PCGG Compare IHI to PJP

        Generic Pharmaceuticals Stocks Recent News

        Date Stock Title
        Nov 21 ABT Major companies that are also popular short-selling stocks
        Nov 21 HSIC HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus
        Nov 21 HSIC Henry Schein to Participate in Investor Conferences in December
        Nov 21 HSIC Henry Schein to acquire medical supplier Acentus
        Nov 20 HSIC Henry Schein: Another Day, Another Purchase
        Nov 20 ABT Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
        Nov 20 HSIC Henry Schein to acquire Acentus
        Nov 20 HSIC Henry Schein to Acquire Acentus, a Leading Supplier of Homecare Medical Products
        Nov 18 HSIC Update: Market Chatter: Henry Schein's Activist Investor Seeks Board Overhaul, Divestment, Cost Cuts
        Nov 18 HSIC S&P 500 Gains and Losses Today: Uber Falls as Trump Eyes Looser Self-Driving Rules
        Nov 18 HSIC Henry Schein extends gain on report of activist stake, push for board changes
        Nov 18 HSIC Exclusive-Activist investor Ananym Capital pushes for changes at Henry Schein, sources say
        Nov 18 HSIC Henry Schein gains amid activist speculation after 13F filing, conference appearance
        Nov 18 ABT Inside a $400 billion bet on the brain-computer interface revolution
        Nov 18 BHC US Supreme Court declines to hear patent dispute over Bausch blockbuster diarrhea drug
        Nov 18 COSM Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets
        Nov 18 BHC PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
        Nov 18 BHC Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
        Nov 17 COSM Cosmos Health Third Quarter 2024 Earnings: Misses Expectations
        Nov 17 ABT First mpox case linked to African outbreak reported in U.S.
        Related Industries: Drug Manufacturers - Specialty & Generic Medical Devices Medical Distribution
        Related Stock Lists: Generic Pharmaceutical Contact Lens Eye Health Care Products Health Products Irritable Bowel Syndrome Life Sciences Pharmaceutical Products S&P 500 Abrasives Acne Actinic Keratosis Animal Health Animal Health Products Atopic Dermatitis Baby Products Biotechnology Blood Glucose Monitoring Cancer Cataract Surgery
        Generic Pharmaceuticals

        Generic Pharmaceuticals are medications that are identical to brand-name drugs in dosage, safety, strength, quality, performance, and intended use. They are typically much less expensive than brand-name drugs and are available in most countries. Generic drugs are usually produced by manufacturers who do not hold the patent for the brand-name drug.

        Browse All Tags